Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- DMSO:
-
Dimethyl sulfoxide
- ER:
-
Endoplasmic reticulum
- GFP:
-
Green fluorescent protein
- HCA:
-
High content analysis
- qHTS:
-
Quantitative high throughput screening
- PBS:
-
Phosphate buffered saline
- PR:
-
Photoreceptor
- RP:
-
Retinitis pigmentosa
References
RetNet: Retinal Information Network. https://sph.uth.edu/retnet/
Cideciyan AV, Aleman TS, Boye SL, Schwartz SB, Kaushal S, Roman AJ, Pang JJ, Sumaroka A, Windsor EA, Wilson JM, Flotte TR, Fishman GA, Heon E, Stone EM, Byrne BJ, Jacobson SG, Hauswirth WW (2008) Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Nat Acad Sci USA 105(39):15112–15117
Barnett PJ (2009) Mathematical modeling of triamcinolone acetonide drug release from the I-vation intravitreal implant (a controlled release platform). Conference proceedings: annual international conference of the IEEE engineering in medicine and biology society IEEE engineering in medicine and biology society conference 2009:3087–3090
Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, Roman AJ, Peden MC, Aleman TS, Boye SL, Sumaroka A, Conlon TJ, Calcedo R, Pang JJ, Erger KE, Olivares MB, Mullins CL, Swider M, Kaushal S, Feuer WJ, Iannaccone A, Fishman GA, Stone EM, Byrne BJ, Hauswirth WW (2012) Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 130(1):9–24
Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell’Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J (2008) Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N England J Med 358(21):2240–2248
Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, Fullmer KR, Bush RA (2006) Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Nat Acad Sci USA 103(10):3896–3901
Swinney DC, Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10(7):507–519
Inglese J, Auld DS, Jadhav A, Johnson RL, Simeonov A, Yasgar A, Zheng W, Austin CP (2006) Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Nat Acad Sci USA 103(31):11473–11478
Chan F, Bradley A, Wensel TG, Wilson JH (2004) Knock-in human rhodopsin-GFP fusions as mouse models for human disease and targets for gene therapy. Proc Nat Acad Sci USA 101(24):9109–9114
Bowen WP, Wylie PG (2006) Application of laser-scanning fluorescence microplate cytometry in high content screening. Assay Drug Dev Technol 4(2):209–221
Xie HQ, Adler R (2000) Green cone opsin and rhodopsin regulation by CNTF and staurosporine in cultured chick photoreceptors. Invest Ophthalmol Vis Sci 41(13):4317–4323
Bradford RL, Wang C, Zack DJ, Adler R (2005) Roles of cell-intrinsic and microenvironmental factors in photoreceptor cell differentiation. Dev Biol 286(1):31–45
Cingolani C, Rogers B, Lu L, Kachi S, Shen J, Campochiaro PA (2006) Retinal degeneration from oxidative damage. Free Radical Biol Med 40(4):660–669
Hackam AS, Strom R, Liu D, Qian J, Wang C, Otteson D, Gunatilaka T, Farkas RH, Chowers I, Kageyama M, Leveillard T, Sahel JA, Campochiaro PA, Parmigiani G, Zack DJ (2004) Identification of gene expression changes associated with the progression of retinal degeneration in the rd1 mouse. Invest Ophthalmol Vis Sci 45(9):2929–2942
Komeima K, Rogers BS, Campochiaro PA (2007) Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa. J Cell Physiol 213(3):809–815
Punzo C, Xiong W, Cepko CL (2012) Loss of daylight vision in retinal degeneration: are oxidative stress and metabolic dysregulation to blame? J Biol Chem 287(3):1642–1648
Usui S, Oveson BC, Lee SY, Jo YJ, Yoshida T, Miki A, Miki K, Iwase T, Lu L, Campochiaro PA (2009) NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa. J Neurochem 110(3):1028–1037
Usui S, Oveson BC, Iwase T, Lu L, Lee SY, Jo YJ, Wu Z, Choi EY, Samulski RJ, Campochiaro PA (2011) Overexpression of SOD in retina: need for increase in H2O2-detoxifying enzyme in same cellular compartment. Free Radical Biol Med 51(7):1347–1354
Chinta SJ, Rane A, Poksay KS, Bredesen DE, Andersen JK, Rao RV (2008) Coupling endoplasmic reticulum stress to the cell death program in dopaminergic cells: effect of paraquat. Neuromolecular Med 10(4):333–342
Huang CL, Lee YC, Yang YC, Kuo TY, Huang NK (2012) Minocycline prevents paraquat-induced cell death through attenuating endoplasmic reticulum stress and mitochondrial dysfunction. Toxicol Lett 209(3):203–210
Kumar A, Singh BK, Ahmad I, Shukla S, Patel DK, Srivastava G, Kumar V, Pandey HP, Singh C (2012) Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity. Brain Res 1438:48–64
Somayajulu-Nitu M, Sandhu JK, Cohen J, Sikorska M, Sridhar TS, Matei A, Borowy-Borowski H, Pandey S (2009) Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10. BMC Neurosci 10:88
Yang W, Tiffany-Castiglioni E, Koh HC, Son IH (2009) Paraquat activates the IRE1/ASK1/JNK cascade associated with apoptosis in human neuroblastoma SH-SY5Y cells. Toxicology Lett 191(2–3):203–210
Chen Q, Prior M, Dargusch R, Roberts A, Riek R, Eichmann C, Chiruta C, Akaishi T, Abe K, Maher PA (2011) Novel neurotrophic drug for cognitive enhancement and Alzheimer’s disease. PloS one 6(12):e27865
Silber BM (2010) Driving drug discovery: the fundamental role of academic labs. Sci Transl Med 2(30):30cm16
Reed JC, White EL, Aubé J, Lindsley C, Li M, Sklar L, Schreiber S (2012) The NIH’s role in accelerating translational sciences. Nat Biotechnol 30(1):16–19
Frearson J, Wyatt P (2010) Drug discovery in academia: the third way? Expert Opin Drug Discov 5(10):909–919
Cheng KCC, Inglese J (2012) A coincidence reporter-gene system for high-throughput screening. Nat Methods 9(10):937
Acknowledgment
We thank John Wilson and Ted Wensel (Baylor College of Medicine) for generously providing Rho-GFP mice, and Patricia Dranchak, Sam Hasson, and Ryan MacArthur of the NIH NCATS DPI for their help and assistance. This work was funded by an FFB/Wynn-Gund Translational Research Acceleration Program Award.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this paper
Cite this paper
Fuller, J. et al. (2014). A High Content Screening Approach to Identify Molecules Neuroprotective for Photoreceptor Cells. In: Ash, J., Grimm, C., Hollyfield, J., Anderson, R., LaVail, M., Bowes Rickman, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 801. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3209-8_97
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3209-8_97
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3208-1
Online ISBN: 978-1-4614-3209-8
eBook Packages: MedicineMedicine (R0)